Medifast, Inc. (MED)
After hours:
| Previous close | 25.72 |
| Open | 25.62 |
| Bid | 24.74 x 2200 |
| Ask | 25.15 x 800 |
| Day's range | 24.67 - 25.65 |
| 52-week range | 24.58 - 109.52 |
| Volume | |
| Avg. volume | 456,287 |
| Market cap | 281.305M |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | 4.04 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.60 (26.41%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | N/A |
- Business Wire
Medifast Announces First Quarter 2024 Financial Results
BALTIMORE, April 29, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2024.
- Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
BALTIMORE, April 15, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
- Business Wire
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
BALTIMORE, February 20, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2023.
